DGX vs NIXXW · P/E 22, rev $5.94B vs rev $612.0K
Quest Diagnostics Incorporated (DGX) versus Nixxy, Inc. (NIXXW) — a side-by-side from cached financials, not a winner call.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Nixxy, Inc. (NIXXW) common stock listed on NASDAQ.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Latest reported NIXXW revenue for 2024-12-31 was $612.0K. Net income was -$22.6M. Revenue was down 80.8% from 2023-12-31 to 2024-12-31. NIXXW currently screens at market cap $0.
DGX currently screens at market cap $19.94B and trailing P/E 22.4. NIXXW currently screens at market cap $0.
Not investment advice. Open the DGX and NIXXW stock pages for the full models.
Not investment advice.